how to administer the investigational radiopharmaceutical 177lu-psma-i&t
Published 1 year ago • 3.5K plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
2:24
eclipse - a randomized phase 3 trial for 177-lu-psma-i&t in patients with mcrpc
-
3:03
vision: tolerability of 177lu-psma-617 by treatment exposure in patients with mcrpc
-
3:41
use of radiopharmaceuticals: updates on ongoing clinical trials
-
1:59
application of radiopharmaceuticals in diagnosis and therapy | animated video | 68ga and 177lu
-
4:25
emerging role of psma based radiopharmaceuticals
-
6:43
does sugar feed prostate cancer? does fatty/adipose tissue attract cancer? | mark moyad, md, mph
-
57:07
imrt 2.0 | session 17 | imrt treatment planning: the “shulman” vmat optimization method
-
18:26
psma & newly-diagnosed #prostatecancer | markscholzmd #alexscholz #pcri
-
1:30:29
clinical trials using lutetium 177 and psma targeting radiopharmaceuticals - dr. francois benard
-
7:09
177 lu psma treatment for prostate cancer (update: fda approved on 3/23/22)
-
2:36
the role of radiopharmaceuticals in the treatment landscape of prostate cancer
-
4:48
vision: lu-177-psma-617 in mcrpc
-
5:27
177lu-psma-617 radionuclide therapy in mcrpc
-
5:37
177lu-psma-617 for the early treatment of prostate cancer
-
6:45
177lu-psma-617 for prostate cancer: therap, vision, upfrontpsma and lutectomy
-
11:23
therap study: lu-psma vs. cabazitaxel #asco20 #anzup
-
1:37
a clever use of radiopharmaceuticals
-
1:34
lu-psma-617 deployment and future of prostate cancer treatment
-
14:39
just the beginning: what's next for radiotheranostics in prostate cancer?
-
1:48
expert discusses fractionated dose 177lu-psma-617 in mcrpc
-
15:35
lu-psma radioligand therapy
-
11:01
lutetium-177: psma guided treatment | #prostatecancer | #markscholzmd | #pcri